Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Anushka Ojha
Institution:
Stony Brook University
Observed institutions:
Manipal Academy of Higher Education,
Stony Brook University
ORCID:
0009-0008-7220-4201
Observed ORCID:
0009-0008-7220-4201
OpenAlex ID:
A5007719871
Light emitting diode (LED) based fluorescence microscopy for tuberculosis detection: a review
2020
·
Anushka Ojha
, Soumyabrata Banik
, et al.
·
Lasers in Medical Science
·
24
Functional and Potential Therapeutic Implication of MicroRNAs in Pancreatic Cancer
2023
·
Amartya Pal
, Anushka Ojha
, et al.
·
International Journal of Molecular Sciences
·
22
PDF
Development of gemcitabine-modified miRNA mimics as cancer therapeutics for pancreatic ductal adenocarcinoma
2024
·
John G. Yuen
, Ga-Ram Hwang
, et al.
·
Molecular Therapy Oncology
·
15
Development of gemcitabine-modified multimodal miR-129 mimic as a novel therapeutic in non-small cell lung cancer
2026
·
Erick M. Intriago
, Amartya Pal
, et al.
·
Molecular Therapy — Nucleic Acids
·
1
Developing a Multimodal miR-15a Mimic to Overcome Gemcitabine and RAS(ON) Inhibitor Daraxonrasib Resistance in Pancreatic Ductal Adenocarcinoma
2026
·
Amartya Pal
, Anushka Ojha
, et al.
·
bioRxiv (Cold Spring Harbor Laboratory)
PDF
Development of gemcitabine-modified miR-15a as a novel, multimodal treatment strategy to overcome 5-FU and oxaliplatin resistance in colorectal cancer
2026
·
Anushka Ojha
, Amartya Pal
, et al.
·
Journal of Experimental & Clinical Cancer Research
Developing a Multimodal miR-15a Mimic to Overcome PARP Inhibitor Resistance in Epithelial Ovarian Cancer
2026
·
Amartya Pal
, Anushka Ojha
, et al.
·
bioRxiv (Cold Spring Harbor Laboratory)
Abstract 2047: Overcoming drug resistance by novel gemcitabine-modified miR-15a in colorectal cancer.
2026
·
Anushka Ojha
, Amartya Pal
, et al.
·
Cancer Research
Abstract 1370: Developing MTX-5-FU-Gem-miR-15a as a multimodal therapeutic strategy to overcome olaparib resistance in epithelial ovarian cancer.
2026
·
Amartya Pal
, Anushka Ojha
, et al.
·
Cancer Research
Abstract A041: Development of MTX-5FU-Gem-miR-15a as a novel miRNA-based therapeutic strategy for epithelial ovarian cancer (EOC)
2025
·
Amartya Pal
, Anushka Ojha
, et al.
·
Cancer Research
Show more works
View as search
Works count:
10
Citation count:
62
H-index:
3
I10-index:
3
Year
Topic
Type